Morgan Stanley Medpace Holdings, Inc. Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 299,806 shares of MEDP stock, worth $88.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
299,806
Previous 237,467
26.25%
Holding current value
$88.1 Million
Previous $78.9 Million
15.79%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding MEDP
# of Institutions
624Shares Held
26MCall Options Held
46.4KPut Options Held
80.8K-
Black Rock Inc. New York, NY2.58MShares$758 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$744 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.19MShares$349 Million0.07% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT829KShares$244 Million1.43% of portfolio
-
State Street Corp Boston, MA783KShares$230 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $9.14B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...